Approval for changes in lead lengths, addition of is-1 connector and enabling bipolar pace/sense capability. the device, as modified, will be marketed under the trade name easytrak 2 and is indicated for chronic, left ventricular pacing and sensing via the coronary veins, when used in conjunction with a compatible guidant cardiac resynchronization therapy (crt) device.